# Promoting Men's Adherence to BRCA1/2 Germline Genetic Testing

> **NCT04683068** · NA · COMPLETED · sponsor: **European Institute of Oncology** · enrollment: 264 (actual)

## Conditions studied

- BRCA1 Mutation
- BRCA2 Mutation
- Psychosocial Factors

## Interventions

- **BEHAVIORAL:** Message comparison

## Key facts

- **NCT ID:** NCT04683068
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-10
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 264 (ACTUAL)
- **Last updated:** 2022-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04683068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04683068, "Promoting Men's Adherence to BRCA1/2 Germline Genetic Testing". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04683068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*